Interim report January-March 2023

5/25/2023

STABLE IN A SHRINKING MARKET

January-March 2023

  • Order bookings amounted to SEK 1,303 million (1,837)
  • Income amounted to SEK 2,116 million (2,052)
  • Operating profit amounted to SEK 1 million (36)
  • Cash flow from operating activities amounted to an outflow of SEK 441 million (5)
  • Cash flow for the period amounted to an outflow of SEK 65 million (28)
  • The loss for the period amounted to SEK 10 million (profit 55)
  • At the end of the period, available cash and cash equivalents totaled SEK 549 million (624)
  • The equity/assets ratio was 30.1 percent (31.7)
  • On April 25, 2023, DOXA Aktiebolag (publ) (”DOXA”) issued a press release announcing to Serneke’s shareholders a public takeover bid to acquire all Series B shares in Serneke. The offer entails six (6) shares in DOXA being offered per Series B share in Serneke. As of April 25, 2023, the offer values each Series B share in Serneke at SEK 35.94, with the total value of the offer amounting to about SEK 1,020 million. Serneke’s Board of Directors unanimously recommends that Serneke’s shareholders accept Doxa’s public takeover bid.


Michael Berglin, CEO Serneke Group, comments:

“In a quarter that tends to be seasonal, with generally lower activity, as well as the currently difficult economic situation, the Group reported increased sales and an operating profit in the black, although barely. In the second half of 2022, we incurred several necessary non-recurring expenses in the form of expenses for streamlining and provisions for disputes, among others, which affected our earnings. In early 2023, we have been able to return to more normal operations in our contracting operations.”

“Order bookings for the first quarter of 2023 were slightly lower than for the same period last year, colored by the general decline in the housing sector. For several quarters now, we have, however, shifted our product mix towards a growing proportion of public properties and public sector clients. We are also conducting a series of contracting projects in the early phases of the partnership format, a number of which are progressing to become orders and construction starts during the year.”
 

Presentation of the Interim Report for January-March 2023
On May 25, 2023 at 9:30 a.m. (CET), Serneke Group will comment on this Interim Report in an online presentation for investors, analysts and the media. The presentation will be in Swedish and can be followed live via webcast at https://www.youtube.com/watch?v=uOk__WkM39o&ab. Presentation materials for the presentation will be available on the website one hour before the webcast begins.

more information, please contact:
Anders Düring, CFO
Tel: +46 70 888 7733
anders.during@serneke.se
 



This information is such that Serneke is required to disclose under the EU Market Abuse Regulation. The information was submitted under the auspices of the contact person stated above, for publication on 25 May 2023 at 08.00 a.m. CET.
 

Serneke is a rapidly growing corporate group active in contracting and project development. The Group was founded in 2002 and today has income of nearly SEK 9.2 billion and approximately 1,200 employees, organized into three business areas: Serneke Sweden, Serneke Invest and Serneke International. Through novel thinking, the Company drives development and creates more effective and more innovative solutions for responsible construction. The Company builds and develops housing, commercial buildings, industri al facilities, public buildings, roads and civil engineering projects, and other infrastructure. The company’s customers consist of both public and commercial clients. The Company’s Swedish units operate nationwide and are organized into five regions: South, West, East, Central and North, and are headquartered in Gothenburg. The Company’s Series B shares (SRNKE) have been listed on the Nasdaq Stockholm exchange since November 2016.
 

More information about Serneke Group AB can be found at www.serneke.se
 

Download article

Download

Appendix

Download

Current news

Press releases